Could skipping antibiotics for prostate biopsy be safe?
NCT ID NCT07557901
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares infection rates in 300 men undergoing transperineal prostate biopsy, half receiving antibiotics and half not. The goal is to see if omitting antibiotics is safe. If proven, it could reduce unnecessary antibiotic use and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fosfomycin-trometamol (antibiotic)
- What this could lead to
- If successful, this could show that antibiotics are not needed for transperineal prostate biopsy, reducing unnecessary drug use and side effects.
- What could go wrong
- This is a single-center study with 300 participants, so results may not apply broadly. If infections occur more often without antibiotics, the practice could be unsafe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS COMPLICATIONS FOLLOWING PROSTATE BIOPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
F.D. Roosevelt teaching hospital
Banská Bystrica, Slovakia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?